{"DataElement":{"publicId":"6013458","version":"1","preferredName":"Genetic Predisposition Syndrome Diagnosis Name","preferredDefinition":"Text term that represents the kind of syndrome diagnosis which increases the risk of cancer.","longName":"6010764v1.0:6013363v1.0","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6010764","version":"1","preferredName":"Genetic Susceptibility Syndrome Diagnosis","preferredDefinition":"An inherited increase in the risk of developing a disease._A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"6010759v1.0:6010762v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"6010759","version":"1","preferredName":"Genetic Susceptibility","preferredDefinition":"An inherited increase in the risk of developing a disease.","longName":"C17939","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic Susceptibility","conceptCode":"C17939","definition":"An inherited increase in the risk of developing a disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C6B87D6-7E72-4526-E053-F662850A92EB","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-25","modifiedBy":"ONEDATA","dateModified":"2017-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6010762","version":"1","preferredName":"Syndrome Diagnosis","preferredDefinition":"A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C28193:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Syndrome","conceptCode":"C28193","definition":"A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C6B64B4-DBED-362D-E053-F662850A3805","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-25","modifiedBy":"ONEDATA","dateModified":"2017-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C6B64B4-DBFE-362D-E053-F662850A3805","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-25","modifiedBy":"COOPERM","dateModified":"2017-11-06","changeDescription":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6013363","version":"1","preferredName":"Syndrome Diagnosis Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"SYN_DIAG_NM","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other (specify)","valueDescription":"Specify Other","ValueMeaning":{"publicId":"4888051","version":"1","preferredName":"Specify Other","longName":"4888051","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"195A90B1-87F5-D292-E050-BB89AD432B03","latestVersionIndicator":"Yes","beginDate":"2015-06-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-06-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CD9A0AB-56F0-70DD-E053-F662850A7724","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"Beckwith-Wiedemann","valueDescription":"Beckwith-Wiedemann Syndrome","ValueMeaning":{"publicId":"2967368","version":"1","preferredName":"Beckwith-Wiedemann Syndrome","longName":"2967368","preferredDefinition":"A genetic syndrome caused by abnormalities in chromosome 11.  It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia.  Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, Rhabdomyosarcoma) and adrenal cortex carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beckwith-Wiedemann Syndrome","conceptCode":"C34415","definition":"A genetic syndrome caused by abnormalities in chromosome 11. It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia. Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, rhabdomyosarcoma) and adrenal cortex carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB32307-57DC-1A4F-E040-BB89AD43618C","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CD9A0AB-5705-70DD-E053-F662850A7724","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"Cirrhosis without an underlying etiology","valueDescription":"Cirrhosis without Underlying Etiology","ValueMeaning":{"publicId":"6013364","version":"1","preferredName":"Cirrhosis without Underlying Etiology","longName":"6013364","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Describes a condition that is present but not active or causing symptoms.: The cause of a disease or abnormal condition.: A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Latent","conceptCode":"C28225","definition":"Describes a condition that is present but not active or causing symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Etiology","conceptCode":"C16390","definition":"The cause of a disease or abnormal condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CD9A0AB-5715-70DD-E053-F662850A7724","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CD9A0AB-572E-70DD-E053-F662850A7724","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"Tyrosinemia","valueDescription":"Tyrosinemia","ValueMeaning":{"publicId":"6013366","version":"1","preferredName":"Tyrosinemia","longName":"6013366","preferredDefinition":"An autosomal recessive inherited metabolic disorder caused by mutations in the FAH, HPD, and TAT genes. It is characterized by deficiency of one of the enzymes that are involved in the metabolism of tyrosine. It results in elevated blood tyrosine levels and accumulation of tyrosine and its byproducts in the liver, kidney, nervous system and other organs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tyrosinemia","conceptCode":"C98640","definition":"An autosomal recessive inherited metabolic disorder caused by mutations in the FAH, HPD, and TAT genes. It is characterized by deficiency of one of the enzymes that are involved in the metabolism of tyrosine. It results in elevated blood tyrosine levels and accumulation of tyrosine and its byproducts in the liver, kidney, nervous system and other organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CD9A0AB-573B-70DD-E053-F662850A7724","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CD9A0AB-5754-70DD-E053-F662850A7724","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"Biliary abnormality","valueDescription":"Biliary Abnormality","ValueMeaning":{"publicId":"6013367","version":"1","preferredName":"Biliary Abnormality","longName":"6013367","preferredDefinition":"A term that refers to the biliary tract structures.: A condition that differs from the usual physical or mental state.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biliary","conceptCode":"C28011","definition":"A term that refers to the biliary tract structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CD9A0AB-5761-70DD-E053-F662850A7724","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CD9A0AB-577A-70DD-E053-F662850A7724","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"Glycogen storage disease","valueDescription":"Glycogen Storage Disease","ValueMeaning":{"publicId":"2593481","version":"1","preferredName":"Glycogen Storage Disease","longName":"2593481","preferredDefinition":"An inherited metabolic disorder characterized either by defects in glycogen synthesis or defects in the breaking down of glycogen. It results either in the creation of abnormal forms of glycogen or accumulation of glycogen in the tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glycogen Storage Disease","conceptCode":"C61272","definition":"An inherited metabolic disorder characterized either by defects in glycogen synthesis or defects in the breaking down of glycogen. It results either in the creation of abnormal forms of glycogen or accumulation of glycogen in the tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28BD3AD6-BCD6-64E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CD9A0AB-578E-70DD-E053-F662850A7724","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"},{"value":"Alpha-1 antitrypsin","valueDescription":"Alpha-1 Antitrypsin Deficiency","ValueMeaning":{"publicId":"3171840","version":"1","preferredName":"Alpha-1 Antitrypsin Deficiency","longName":"3171840","preferredDefinition":"A genetic disorder characterized by decreased alpha-1 antitrypsin activity in the lungs and blood and deposition of alpha-1 antitrypsin protein in the hepatocytes. These abnormalities result from defective production of alpha-1 antitrypsin and lead to the development of emphysema, cirrhosis, and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alpha-1 Antitrypsin Deficiency","conceptCode":"C84397","definition":"A genetic disorder characterized by decreased alpha-1 antitrypsin activity in the lungs and blood and deposition of alpha-1 antitrypsin protein in the hepatocytes. These abnormalities result from defective production of alpha-1 antitrypsin and lead to the development of emphysema, cirrhosis, and liver failure.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97DDA7EA-0146-07E7-E040-BB89AD4351C6","latestVersionIndicator":"Yes","beginDate":"2010-12-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5CD9A0AB-57A3-70DD-E053-F662850A7724","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"ONEDATA","dateModified":"2017-10-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CD9A0AB-56DA-70DD-E053-F662850A7724","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"COOPERM","dateModified":"2017-11-06","changeDescription":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"7589448","version":"1","longName":"Pediatric Liver Cancer","context":"OCG"}]}],"AlternateNames":[{"name":"syndrome_diagnosed","type":"HCMI Name","context":"OCG"}],"ReferenceDocuments":[{"name":"Syndrome diagnosed","type":"Preferred Question Text","description":"Syndrome diagnosed","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CDB21E6-3BCB-6E11-E053-F662850ACFBB","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"COOPERM","dateModified":"2017-11-06","changeDescription":"Created for request 8.21.17 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}